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The coordination of tissue function is mediated by gap junctions (GJs) that enable direct
cell–cell transfer of metabolic and electric signals. GJs are formed by connexins of which
Cx43 is most widespread in the human body. In the brain, Cx43 GJs are mostly found in
astroglia where they coordinate the propagation of Ca2+ waves, spatial K+ buffering, and
distribution of glucose. Beyond its role in direct intercellular communication, Cx43 also
forms unapposed, non-junctional hemichannels in the plasma membrane of glial cells.
These allow the passage of several neuro- and gliotransmitters that may, combined with
downstream paracrine signaling, complement direct GJ communication among glial cells
and sustain glial-neuronal signaling. Mutations in the GJA1 gene encoding Cx43 have
been identified in a rare, mostly autosomal dominant syndrome called oculodentodigital
dysplasia (ODDD). ODDD patients display a pleiotropic phenotype reflected by eye,
hand, teeth, and foot abnormalities, as well as craniofacial and bone malformations.
Remarkably, neurological symptoms such as dysarthria, neurogenic bladder (manifested
as urinary incontinence), spasticity or muscle weakness, ataxia, and epilepsy are other
prominent features observed in ODDD patients. Over 10 mutations detected in patients
diagnosed with neurological disorders are associated with altered functionality of Cx43
GJs/hemichannels, but the link between ODDD-related abnormal channel activities and
neurologic phenotype is still elusive. Here, we present an overview on the nature of
the mutants conveying structural and functional changes of Cx43 channels and discuss
available evidence for aberrant Cx43 GJ and hemichannel function. In a final step, we
examine the possibilities of how channel dysfunction may lead to some of the neurological
manifestations of ODDD.
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INTRODUCTION: ODDD MUTATIONS, CLINICAL
MANIFESTATIONS AND REVIEW FOCUS
Oculodentodigital syndrome or oculodentodigital dysplasia
(ODDD, OMIM #164200) is a mostly autosomal dominant dis-
ease caused by mutations in the GJA1 gene which is located on
chromosome 6 (q21-q23.2). ODDD is a rare disease (prevalence
< 1/1,000,000 1) and symptoms have been mostly described in
Caucasian families; it is uncertain though whether this is a matter
of clustering or of inconsistent screening in other populations. In
the affected families, male and female patients are found in equal
numbers while in sporadic forms of ODDD, females seem to be
more susceptible (reviewed in Paznekas et al., 2009; Avshalumova
et al., 2013).
GJA1 encodes for one of the most abundant connexin (Cx)
proteins, Cx43. Cxs are a family of transmembrane proteins
with molecular weights (MW) varying from 26 to 60 kilodal-
tons (kDa) on which the current nomenclature is based (Cx43
has a MW of ∼43 kDa). In vertebrates, Cxs are the building
blocks of gap junction (GJ) channels, intercellular channels that
connect the cytoplasm of two neighboring cells. A GJ channel
1http://www.orpha.net
consists of two hemichannels (HCs), each composed of six Cx
proteins and delivered by each of the coupled cells. Cx43 is ubiq-
uitously present in the human body in a large array of tissues
and cells (reviewed in Laird, 2006). As a result, ODDD patients
exhibit a pleiotropic phenotype with manifestations in a large
variety of organ systems. Externally, mostly eyes, teeth, hands
and feet are affected. Typical craniofacial dysmorphisms include
a thin nose with hypoplastic alae nasi, small anteverted nares and
prominent columnella. Some patients additionally have dysplas-
tic ears. Ophthalmological anomalies include microphthalmia,
microcornea, iris abnormalities, cataracts, glaucoma and opti-
cal neuropathy. Malformations of the extremities are another
hallmark of ODDD and include syndactyly of fingers and toes.
Additionally, campylodactyly (fixed flexion deformity of fingers
and toes) and clinodactyly (lateral curvature of the fingers) are
frequently observed. In the oral region, mandibular overgrowth,
cleft lip, and cleft palate may be present. Abnormalities in primary
and permanent teeth such as microdontia, partial anodontia,
enamel hypoplasia, caries, and early tooth loss are observed in
most patients. Brittle nails and hair abnormalities sometimes
appear and skin diseases like palmoplantar keratoderma and sub-
clinical wound healing defects are possible as well (Paznekas et al.,
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2003; Gong et al., 2006; Thibodeau et al., 2010; Churko et al.,
2011; Amano et al., 2012).
In addition to this large variety of physically observable fea-
tures, the disease is also characterized by cardiac and neurological
malfunctioning. The cardiac phenotype is observed in 3% of the
ODDD patients and includes endocardial cushion defects, atrial
or ventricular septum defects, recurrent ventricular tachycardia,
atrioventricular block, and idiopathic atrial fibrillation (Paznekas
et al., 2003, 2009). Cardiac arrhythmia caused by a Cx43mutation
(E42K) has been associated with “sudden infant death syndrome”
(Van Norstrand et al., 2012), making it plausible that some of
the ODDDmutations result in a cardiac phenotype. Neurological
symptoms are not universally seen, but about 30% of the patient
population has been diagnosed with neurological problems that
include conductive hearing loss, dysarthria (speech articulation
problems), neurogenic bladder (voiding problems), ataxia (gait
disturbance), muscle weakness, spasticity, and seizures. MRI
imaging studies have brought up diffuse bilateral abnormalities
in the subcortical cerebral white matter, possibly indicating a slow
progressive leukodystrophy. Mental retardation may occur but is
rare (Paznekas et al., 2003, 2009; Amador et al., 2008; Joss et al.,
2008; Furuta et al., 2012). Of note, in most families, the appear-
ance of neurological symptoms is unpredictable, but in 4 families
genotyped for having the L90V, L113P, K134N, or G138Rmutant,
all ODDD patients exhibit neurological traits (Paznekas et al.,
2009). Cardiac and neurological manifestations in ODDD have
only started to emerge in the past decade and the list of “new”
ODDD features still seems to expand continuously. Brice and
co-workers have for instance recently described a case of lym-
phedema in ODDD (Brice et al., 2013). Given the low prevalence,
the high pleiotropy and the still growing list of previously unno-
ticed ODDD features, currently, there are no clear data available
about the life expectancy of the patients.
In this review, we focus on the neurological manifestations
of ODDD and explore how Cx43 mutations and consequent
channel aberrations may link to some of these manifestations
(Table 1).We start with an overview of connexins and its channels
(section Connexin Channels: Gap Junctions and Hemichannels),
provide an in depth analysis of the consequence of ODDD muta-
tions on channel function (section ODDD-LinkedMutations and
Cx43 Channel Function) and end by examining how channel
dysfunction may lead to alterations in neural tissue functioning
(section Neurological Phenotype in ODDD—Link to Aberrant
Cx43 Channels). Several excellent reviews have highlighted each
of these aspects (Kielian, 2008; Laird, 2008, 2010; Chew et al.,
2010; Orellana et al., 2011; Abrams and Scherer, 2012; Eugenin
et al., 2012); here we aimed to correlate channel dysfunction with
neurological manifestations and explore possible relations in the
framework of currently available knowledge.
CONNEXIN CHANNELS: GAP JUNCTIONS AND
HEMICHANNELS
Cxs form two kinds of functional channels: GJs and HCs. GJs
mediate the direct diffusion of ions and molecules with MWs
up to 1.5 kDa, including inositol 1,4,5 trisphosphate (IP3), cyclic
nucleotides, and energy molecules such as ATP (reviewed in
Alexander and Goldberg, 2003), thereby contributing to the
coordination of cell function in several organs and tissues.
GJ channels are for instance implicated in the propagation of
intercellular Ca2+ waves (ICWs) (reviewed by Leybaert and
Sanderson, 2012), metabolic and electric coupling in astro-
cytes and cardiomyocytes (Rouach et al., 2008; Meme et al.,
2009; Desplantez et al., 2012), exchange of bone modulating
molecules (reviewed in Batra et al., 2012) and synchronization
of smooth muscle cell contraction in the bladder and uterus
(Miyoshi et al., 1996; Neuhaus et al., 2002). Moreover, GJs may
also spread cell death signals to neighboring cells, thereby con-
tributing to tissue/organ damage in pathology (Decrock et al.,
2012). HCs can be present both as GJ precursors in the plasma
membrane (PM) or as non-junctional channels, not incorpo-
rated into GJs. For a long time, it was thought that HCs remain
closed until they form a GJ channel, since uncontrolled HC
opening would lead to membrane depolarization and depletion
of essential molecules from the cytoplasm, ultimately leading
to cell dysfunction and possibly cell death. The first evidence
of functional HCs, derived from in vitro work whereby Cx46
was expressed in Xenopus laevis oocytes, confirmed that HC
opening resulted in uptake of Lucifer yellow, but also in depo-
larization and cell death (Paul et al., 1991). Research over the
past decades has identified numerous scenarios in which HCs
are activated (see section ODDD-Linked Mutations and Cx43
Channel Function). HCs have been shown to be involved in dif-
ferent forms of paracrine signaling through the release of ATP
(Kang et al., 2008), glutamate (Ye et al., 2003), glutathione (Rana
and Dringen, 2007), NAD+ (Goodenough and Paul, 2003), and
prostaglandins (Jiang and Cherian, 2003; Orellana et al., 2011).
HC-mediated ATP release functions as a paracrine signal in
the propagation of ICWs (Leybaert and Sanderson, 2012) and
evidence is accruing that HCs may additionally contribute to
“center-surround” antagonism in the retina (Kamermans et al.,
2001; Goodenough and Paul, 2003), osteogenesis (reviewed in
Civitelli, 2008; Batra et al., 2012), regulation of vascular perme-
ability (De Bock et al., 2011), central chemoreception (Huckstepp
et al., 2010), atherosclerotic plaque formation (Wong et al., 2006),
induction of astrogliosis (O’Carroll et al., 2008), ischemia-related
cell death (Danesh-Meyer et al., 2008, 2012; Davidson et al.,
2012; Wang et al., 2013a,b and reviewed in Contreras et al., 2004;
Bargiotas et al., 2009) as well as in the propagation of apop-
totic signals (Decrock et al., 2009). The role of HCs has been
heavily debated since the discovery of pannexin channels, trans-
membrane channels that have similar tissue distribution and
properties as HCs but are not likely to form GJ channels (Spray
et al., 2006; Iglesias et al., 2009; Scemes, 2012). Much of the
published data on the possible role of both HCs and pannexin
channels is based on indirect measures that might be prone to
misinterpretation and these issues are considered in detail in
another review in this Frontiers Research Topic (Giaume et al.,
2013).
CONNEXIN LIFE CYCLE AND CHANNEL ASSEMBLY
Because of the relatively short Cx half-life (1–6 h), there is a con-
tinuous synthesis and breakdown of the protein, enabling fast
adaptation of GJ intercellular communication (GJIC) to the phys-
iological needs of the tissue (reviewed in Herve et al., 2007;
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Table 1 | Overview of ODDD-linked mutations in different Cx43 domains, their effect on Cx channel properties and the associated neurologic
phenotypes.
NH2 Proposed role in:
• fast gating
• stabilization of open conformation
Influence on GJs Influence on HCs Neurologic phenotype
G2V Normal number of GJ plaques
No GJIC
DN effect
n.a. n.a.
G2fs n.a. n.a. Psychomotor regression
Seizures
Hypomyelination
Atrophy
D3N Normal number of GJ plaques
No GJIC
DN effect
n.a. Neurogenic bladder
UMN dysfunction
L7V Normal number of GJ plaques
No GJIC
DN effect
n.a. n.a.
L11P ↓ Presence in PM
↓ Number of GJ plaques
No GJIC
DN effect
n.a. No neurological findings
L11F n.a. n.a. Sensorineural deafness
Y17S ↓ Presence in PM
↓ Number of GJ plaques
No GJIC
DN effect
no HC activity UMN dysfunction
MRI white matter changes urinary incontinence
S18P ↓ Presence in PM
↓ Number of GJ plaques
No GJIC
DN effect
n.a. No neurological findings
TM1 Proposed role in:
• Pore lining
• Loop gating
Influence on GJs Influence on HCs Neurologic phenotype
G21R ↓ Number of GJ plaques
No GJIC
DN effect
no HC activity UMN dysfunction
G22E Normal GJ plaques n.a. MRI white matter changes
K23T Normal GJ plaques n.a. UMN dysfunction
MRI white matter changes
Tremor
V24A n.a. n.a. Sensorineural hearing loss
W25C n.a. n.a. Motor deficits
Sensory deficits (peripheral)
Lesions in brain and brainstem
(Continued)
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Table 1 | Continued
I31M ↓ Presence in PM
↓ Number of GJ plaques
↓ Phosphorylation
No GJIC
↑ HC activity n.a.
R33X No presence in PM
DN effect
n.a. UMN dysfunction
MRI white matter changes
MRI gray matter changes
Speech delay
A40V ↓ Number of GJ plaques
No GJIC
no HC activity Gait difficulties
Urinary urgency
E42K Normal (number of) GJ plaques
No GJIC
n.a. n.a.
EL1/2 Proposed role in:
• Stabilization protein structure
• HC docking
• Loop gating
• Permselectivity?*
• Heterotypic compatibility
Influence on GJs Influence on HCs Neurologic phenotype
Q49K Normal presence in PM
No GJIC
DN effect
n.a. No neurologic findings
Q49P n.a. n.a. Urinary incontinence
F52dup Intracellular retention
No GJIC
No DN effect
no HC activity No neurologic findings
R76S Normal presence in PM
No GJIC
n.a. MRI white matter changes
Epilepsy
R76H Normal presence in PM
Normal GJ plaques
↓ GJIC#
No DN effect
n.a. n.a.
H194P ↓ Presence in PM
No GJIC
normal HC activity No neurological findings
R202H Intracellular retention
↓ Number of GJ plaques
No GJIC
No DN effect (except on dye coupling)
n.a. No neurological findings
TM2 Proposed role in:
• Chemical gating (pHi)
• Permselectivity?*
Influence on GJs Influence on HCs Neurologic phenotype
V85M n.a. n.a. Spastic paraplegia‡
L90V ↓ Number of GJ plaques
↓ GJIC
DN effect
no HC activity Urinary incontinence
Spastic paraplegia
Epilepsy
MRI white matter changes
(Continued)
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Table 1 | Continued
H95R n.a. n.a. Urinary incontinence
MRI white matter changes
Spasticity
V96A n.a. n.a. MRI white matter changes
CL Proposed role in:
• Fast gating
• Chemical gating (pHi and [Ca2+]i)
Influence on GJs Influence on HCs Neurologic phenotype
K102N Normal GJ plaques n.a. MRI white matter changes
Urinary incontinence
L106P n.a. n.a. Urinary incontinence
Spasticity
L113P n.a. n.a. Spastic paraparesis
UMN dysfunction
MRI white matter changes
I130T ↑ Presence in PM
↓ Number of GJ plaques
↓ GJIC
↓ Phosphorylation
No DN effect
no HC activity Spastic paresis
Epilepsy
Brain atrophy/hypoplasia
Urinary incontinence
MRI white matter changes
K134E ↓ Number of GJ plaques
↓ GJIC
no HC activity UMN dysfunction
MRI white matter changes
K134N ↓ Number of GJ plaques
↓ GJIC
n.a. UMN dysfunction
G138R ↑ Presence in PM
Normal GJ plaques
No GJIC
DN effect
↑ HC activity Spastic bladder paraparesis?
Tremor
UMN dysfunction
Urinary incontinence
MRI white matter changes
G143S ↑ Presence in PM
Normal GJ plaques
No GJIC
DN effect
↑ HC activity n.a.
TM3 Proposed role in:
• Cx isoform compatibility in heteromeric channels
Influence on GJs Influence on HCs Neurologic phenotype
T154A Normal GJ plaques
↓ GJIC
DN effect
n.a. MRI white matter changes
Psychomotor delay
Gait difficulties
UMN dysfunction
Urinary incontinence
T154N n.a. n.a. Tremor
Spastic paraparesis
(Continued)
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Table 1 | Continued
TM4
Influence on GJs Influence on HCs Neurologic phenotype
V216L ↓ Amount of GJ plaques
↓ GJIC
↓ Phosphorylation
DN effect
n.a. Spasticity
UMN dysfunction
MRI white matter changes
Neurogenic bladder/Urinary incontinence
Hyperreflexia
S220Y n.a. n.a. Developmental and language disorder
CT Proposed role in:
• Fast gating
• Chemical gating
• Interacts with cytoskeletal binding partners and scaffolding proteins
• Main target for post-translation modifications
Influence on GJs Influence on HCs Neurologic phenotype
fs230 No presence in the PM
DN effect
n.a. No neurological findings
fs260 No presence in the PM
DN effect
n.a. No neurological findings
c.932delC No presence in the PM
DN effect
n.a. n.a.
For references see text. Neurological traits are from Paznekas et al. (2003) and Abrams and Scherer (2012) and references therein, unless indicated.
*The role of the EL domains in the determination of Cx channel permselectivity has been suggested based on observations in Cx46 channels. TM2 is implicated in
regulating permselectivity of Cx26 channels. Thus far, nothing is known on the role of these domains in regulating permselectivity of Cx43 channels.
#Only for certain exogenous markers. With other markers, GJIC is similar to WT Cx43.
‡Quintáns et al., 2013
DN, dominant negative effect; n.a., data not available; PM, plasma membrane; UMN, upper motor neuron.
Mutants in italic font are inherited in an autosomal recessive manner.
Rackauskas et al., 2010). This is for instance illustrated in the
myometrium, where steroid hormones control the expression
level of Cxs before and after parturition (Risek et al., 1990).
Like most transmembrane proteins, Cxs are co-translationally
integrated into the rough endoplasmic reticulum (ER) mem-
brane where they adopt their native transmembrane config-
uration (Falk, 2000; Vanslyke et al., 2009). Hydropathy plots
reveal that all Cx proteins share a common topology: four
transmembrane alpha-helices (TM1-4) are connected through
two extracellular loops (EL1-2). In each loop, three cysteine
residues form intramolecular disulphide bonds that are required
for appropriate folding of the protein (Dahl et al., 1992; Foote
et al., 1998). The Cx protein further contains three intracellular
domains: a cytoplasmic loop (CL), an amino-terminal domain
(NT), and the carboxyl-terminal region (CT). The best con-
served protein regions are the ELs and the TM domains, whereas
the CT- and CL-regions show marked divergence (reviewed in
Nicholson, 2003; Saez et al., 2003; Wei et al., 2004). The sub-
sequent oligomerization of Cx proteins into HCs starts in the
ER, progressing to the trans-Golgi network (Falk, 2000; Vanslyke
et al., 2009). During this process, newly synthesized HCs remain
closed in order to protect and maintain the integrity of the
lumens of the intracellular compartments (Moreno, 2005; Laird,
2006).
After leaving the ER, Cxs first pass the ER-Golgi intermediate
compartment and then transit through the cis- and trans-Golgi
network before being shuttled to the PM. Pleomorphic vesi-
cles and tubular extensions departing from the Golgi apparatus
contribute to the delivery of HCs to the PM (Gaietta et al.,
2002; Laird, 2006). It is not entirely clear to what extent post-
translational modifications are required for Cx transport to the
PM. Some data suggest that Cx43 is transiently phosphorylated
early in the secretory pathway, but the vast majority of phospho-
rylation is thought to occur at the cell surface (Lampe et al., 2000;
Solan and Lampe, 2007 and reviewed in Lampe and Lau, 2004),
where it plays a complex role in Cx channel gating (see further).
Notably, once inserted into the cell membrane, HCs undergo spe-
cific adhesions and dock with HCs of neighboring cells to form
GJs. Hundreds to thousands of GJ channels cluster in plaques
at the cell–cell interface with newly formed GJs located at the
border of the plaque and older channels located centrally. These
central channels are targeted for internalization and degradation
of GJ channels (reviewed in Goodenough and Paul, 2003; Laird,
2006).
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Internalization is mediated through large double-membrane
bound vesicles that contain a complete GJ channel. These vesi-
cles are called “annular junctions” or “connexosomes” (Gaietta
et al., 2002; Laird, 2006) and also contain Cx-binding proteins
and molecules that function as chaperones for internalization
and intracellular degradation through the proteasomal or lyso-
somal pathway (Qin et al., 2003; Thevenin et al., 2013). Cxs have
been shown to be a substrate for ubiquitination that is known
to guide proteins to proteasomes. Connexosomes are identified
in the majority of cell types, but are for instance difficult to
find in hepatocytes. It therefore remains possible that Cxs are
additionally internalized and degraded through the endosomal
cascade. Furthermore, internalization of Cx43 has been suggested
to occur via a clathrin-mediated, caveolae-dependent process.
Clearly, more studies are required to investigate all possible path-
ways of internalization/degradation. The proteasomal pathway
may be responsible for ER-associated degradation, while lyso-
somes degrade Cxs that are recycled to the PM trough endosomes
(Laird, 2006).
ODDD-LINKED MUTATIONS AND Cx43 CHANNEL FUNCTION
Cx43 MUTATIONS AND CHANNEL GATING
Collectively, there are over 62, mostly missense, mutations found
throughout the expanse of the Cx43 protein that are associ-
ated with ODDD. All Cx domains have specific functions, be
it in Cx trafficking, Cx assembly or channel gating. In contrast
to “benign” polymorphisms that have no discernible effect on
Cx43 channel function, a minority of mutants promote channel
opening/function; however, most mutants carry loss-of-function
mutations and may involve those leading to inappropriate mem-
brane sorting, those leading to improper folding, interfering with
the HC docking process, and those giving rise to altered permse-
lectivity or gating. The latter implies a fast and reversible shift in
the channel’s conductive properties which can be due to confor-
mational changes or which can be mediated by Cx-linked adaptor
molecules and proteins (Bukauskas et al., 2000; Cottrell et al.,
2003; Herve et al., 2007; Moreno and Lau, 2007).
Cx channels—both GJs and HCs—are sensitive to changes
in voltage, intracellular pH and [Ca2+]i, allowing swift adapta-
tions (faster than those brought about by assembly/disassembly)
of GJIC and paracrine signaling to comply to the specific needs
of the tissue. In terms of voltage-dependent channel gating, GJs
are influenced mainly by the transjunctional voltage (Vj) which
defines the difference in voltage measured between two coupled
cells. In contrast, HCs are highly sensitive toVm: they remain pref-
erentially “silent” at inside negative potentials but are activated
upon depolarization by a gating mechanism that resembles gat-
ing transitions associated with the docking of extracellular loop
domains; therefore this gating is also referred to as loop gating (or
slow gating) (Trexler et al., 1996; Bukauskas and Verselis, 2004;
Gonzalez et al., 2006; Verselis et al., 2009). Loop gating represents
transitions between the fully open and closed states whereas fast
(<1ms) HC gating involves transitions to long-lasting substates.
Chemical gating, achieved by changes in the intra- or extracel-
lular environment, much resembles gating transitions observed
with slow voltage gating; therefore, it has been proposed that both
phenomena are mediated by the same mechanisms.
Cx43 mutations are found in all protein domains, each of
which has been associated with specific functions in terms of
channel oligomerization, trafficking, gating and permeability.
Importantly, many of the knownmutations causing ODDD occur
in residues that are highly conserved throughout the animal king-
dom (Paznekas et al., 2003), hinting toward their importance in
channel regulation. Below, we discuss the different Cx43 muta-
tions that have been characterized in terms of trafficking, channel
assembly and channel function. Unfortunately though, for most
mutant channels there is not yet a clear structural-functional
correlation that would allow a better understanding of what is
going wrong with the channels. The effects of the Cx43 muta-
tions are often not predictable from their location in the primary
structure and mutations located at different domains may cause
similar channel dysfunction phenotypes, ultimately leading to the
ODDD phenotype.
N-TERMINAL Cx43 MUTATIONS
Deletion of the first N-terminal amino acids (AAs 2–7) disables
Cx43 trafficking and most of the Cx43 protein is retained in
the intracellular compartment. Overall, the Y17S mutation has
similar effects (Shao et al., 2012), although a few plaque-like
structures remained observable at the PM (Shibayama et al., 2005;
Lai et al., 2006). Nevertheless, given the problematic trafficking
of this mutant, neither HC activity nor GJIC was detected (Lai
et al., 2006). Unfortunately, fairly little is known on the role of the
Cx43 N-terminal domain in terms of oligomerization or traffick-
ing. Most of the other N-terminal missense mutations, including
G2V, D3N, L7V, L11P, and S18P, do allow a normal Cx life cycle,
but result in non-functional GJs, as evidenced by the lack of dye
transfer and the absence of electrical coupling (Shibayama et al.,
2005; Churko et al., 2011; Shao et al., 2012). In thesemutant chan-
nels, the closed state is thus relatively more stable than the open
one. Importantly, these mutant proteins exert a dominant nega-
tive effect on WT Cx43 in terms of coupling, indicating that the
patients are likely experiencing more than 50% loss of normal
Cx43 function, despite having one functional allele (Shao et al.,
2012).
A hydrophobic core built around W4 has been put forward
as a structural determinant of the Cx43 N-terminal domain,
governing interactions with the TM1 domain. Replacement of
G2 with a valine residue was suggested to introduce additional
hydrophobic interactions, not present in the WT channel that
would abolish NT-TM1 interactions (Shao et al., 2012). Based
on electron crystallography of Cx26 channels and electrophysio-
logical studies performed in Cx46 channels, interactions between
the NT and the TM1 domains are suggested to keep the chan-
nel in the open conformation (Maeda et al., 2009; Kronengold
et al., 2012). Preventing NT-TM1 interactions may thus be one
mechanism by which the mutants result in non-functional GJ
channels.
Cx43 MUTATIONS IN THE TRANSMEMBRANE DOMAINS
The crystal structure of a C-terminally truncated Cx43 channel
at 7.5 Å resolution indicates the presence of 24 transmembrane
α-helices within each hemichannel, grouped in two concentric
rings around the central pore (Unger et al., 1997, 1999); however,
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there has been controversy regarding the identities of the prin-
cipal pore-lining segments. The substituted cysteine accessibility
method (SCAM) that enables the identification of pore lining
residues, has pointed out that TM3 might delineate the inner
pore of Cx32 GJs (Skerrett et al., 2002); however, currently, most
evidence points to the amphipathic TM1 as the major pore-
lining domain in channels composed of Cx46 (Zhou et al., 1997;
Kronengold et al., 2003a,b), Cx50 (Verselis et al., 2009) Cx32 (Oh
et al., 1997; Tang et al., 2009) and Cx26 (Sanchez et al., 2010). The
crystal structure of a Cx26 channel at 3.5 Å resolution confirms
that TM1, but also TM2, are part of the inner lumen wall, whereas
TM3 and TM4 face the hydrophobic environment (Maeda et al.,
2009).
In TM1, mutants G21R, G22E, K23T, I31M, R33X, A40V,
and E42K have all been identified in ODDD patients. Of these
G21R, G22E, K23T, and E42K [the latter causing sudden infant
death syndrome (Van Norstrand et al., 2012)], encounter nor-
mal trafficking to the PM and insertion into GJ plaques; yet
cells are not electrically coupled (data on channel function of
G22E and K23T mutant channels are still lacking) (Roscoe et al.,
2005; Shibayama et al., 2005; Abrams and Scherer, 2012; Van
Norstrand et al., 2012; Huang et al., 2013). When the Cx43-
G21R mutant is co-expressed with endogenous WT Cx43, it
negatively influences dye coupling (Shibayama et al., 2005). Both
I31M and A40V mutants exhibit disturbed membrane inser-
tion with just a fraction of the channels present in GJ plaques;
these were, however, not sufficient to sustain GJIC (Shibayama
et al., 2005; Dobrowolski et al., 2007). With respect to HC activ-
ity, G21R and A40V do not form functional HCs but I31M
mutant channels release more ATP compared to the Cx43 WT.
The half-life of the I31M mutant was not prolonged pointing
to altered gating mechanisms or a shift in permselectivity (Lai
et al., 2006; Dobrowolski et al., 2007). Additionally, Cx43-I31M
presents with reduced phosphorylation that is, up to a certain
degree, required for proper GJIC (Dobrowolski et al., 2007).
This is quite surprising as Cx43 has thus far not been shown
to be phosphorylated in transmembrane domains (reviewed in
Johnstone et al., 2012; Marquez-Rosado et al., 2012). In addi-
tion, isoleucine residues are not generally direct targets for
phosphorylation. Thus, it is more likely that a phosphoryla-
tion in TM1 is associated with conformational changes that
somehow mask candidate phosphorylation sites in other protein
domains.
Known mutations located in TM2 (L90V), TM3 (T154A), or
TM4 (V216L) all form channels that are present as punctae in
the PM, but the coupling capacity of each mutant channel is
reduced. All mutants furthermore exert dominant negative effects
on WT Cx43 when in a heteromeric or heterotypic conforma-
tion (McLachlan et al., 2005; Shibayama et al., 2005; Beahm
et al., 2006; Churko et al., 2011). The H95R mutant (TM2) has
additionally been described in an ODDD patient, but unfortu-
nately, the manuscript provided no functional data (Honkaniemi
et al., 2005). Earlier data indicate that this residue is involved in
pH sensitivity of Cx43 channels (Ek et al., 1994): introducing
a negative or positive charge at position 95 yields GJ chan-
nels that exhibit reduced or increased sensitivity to intracellular
acidification, respectively. Finally, residues located in TM2 have
been proposed to play a role in determining permselectivity.
Permeation of the Ca2+ mobilizing messenger IP3 for instance,
is abolished in GJ channels composed of the mutant Cx26-V84L
which is associated with hereditary deafness. The mutant protein
has, however, no effect on unitary conductance and permeability
to Lucifer yellow, which remain indistinguishable fromWT Cx26
(Beltramello et al., 2005). This suggests that subtle structural
modifications in the channel pore may selectively hinder the pas-
sage of biologically relevantmolecules, possibly by altering certain
interactions between the permeant and the channel pore. As this
valine is highly conserved (V85 in Cx43) it may well be involved in
determining IP3 transfer through Cx43 channels. ODDD patients
carrying a V85M mutant were recently identified (Fenwick et al.,
2008; Quintáns et al., 2013), but again, the implications of this
mutant on channel trafficking/gating/permselectivity were not
studied.
Cx43 MUTATIONS IN THE EXTRACELLULAR LOOPS
The extracellular loops are characterized by conserved, cysteine-
rich patterns (CX6CX3C in EL1 and CX4/5CX5C in EL2), and
intramolecular disulphide bridges in and between the ELs stabi-
lize the protein’s tertiary structure (Dahl et al., 1992; Bruzzone
et al., 1996; Foote et al., 1998). In Cx43 these involve C54, C61
and C65 in EL1 and C187, C192 and C198 in EL2. Mutations of
each of these cysteines could result in distorted loops resulting in
improper protein folding and retention in intracellular compart-
ments. Although mutations of conserved cysteines have not been
associated with ODDD, twomutations that lie in direct proximity
to conserved cysteine residues (F52dup and Cx43-R202H) can-
not be traced back to the PM (Shibayama et al., 2005; Lai et al.,
2006). Other mutants (Q49K, R76S/H, H194P) are inserted into
the lipid bilayer (Sokolova et al., 2002; McLachlan et al., 2005;
Shibayama et al., 2005; Dobrowolski et al., 2007; Abrams and
Scherer, 2012; Huang et al., 2013); yet, electrical coupling is abol-
ished (Sokolova et al., 2002; McLachlan et al., 2005). Based on
a model proposed by Foote et al. in which the interdigitation
of apposed ELs is required for docking and thus GJ formation
(Foote et al., 1998), even those mutants that are present in the
PM, may not form GJs due to distorted loops. This is further
supported by the fact that HC activity of Cys-less Cx43 mutant
channels appears normal both in vitro and in vivo (Bao et al.,
2004; Tong et al., 2007). Also for ODDD-linked mutants like
H194P in which the insertion of a proline induces a kink in the
EL2 domain, HC activity is normal (Dobrowolski et al., 2007).
In addition, those mutant proteins that cannot traffic to the PM
in a homomeric configuration, can do so when assembled in
a heteromeric channel with WT Cx43 (Shibayama et al., 2005;
Lai et al., 2006). Interestingly, main and subconductance states
of these WT:R202H and WT:F52dup channels were not differ-
ent from homomeric WT channels (Shibayama et al., 2005). The
single channel conductance of Cx43-R76H channels was substan-
tially reduced compared to WT Cx43 channels (Huang et al.,
2013). Slow voltage gating of Cx channels generally involves
the coordinated response of all Cx monomers in the channel
(Bukauskas and Verselis, 2004; Kwon et al., 2012). This might
explain why a remaining electrical coupling is observed in het-
eromeric WT:R202H channels. At the same time, however, the
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mutant proteins may narrow the pore as compared to homo-
meric WT channels, preventing the diffusion of larger molecules
like Lucifer yellow while leaving its electrical conduction intact
(Shibayama et al., 2005).
Cx43 MUTATIONS LOCATED IN THE CYTOPLASMIC LOOP
It is now firmly established that the CL domain is of utmost
importance for Cx channel gating. It has for instance been shown
to contain the preferred interaction site for calmodulin (CaM;
region 136–158) and as such, to mediate the closure of GJ
channels in response to increasing [Ca2+]i (Zhou et al., 2007;
Myllykoski et al., 2009). Indeed, Ca2+-induced closure of GJs is
likely to be mediated by intracellular effector proteins since the
uncoupled state may persist long after [Ca2+]i has been restored
(Cotrina et al., 1998; Lurtz and Louis, 2003, 2007). Even more
important, it is now widely accepted that the L2 region (second
half of the CL; amino acids 119–144) serves as a receptor domain
for the CT and that this CT-CL interaction, also known as the
ball-and-chain mechanism, is implicated in both voltage gating
and chemical gating of GJs by intracellular pH changes (Ek et al.,
1994; Ek-Vitorin et al., 1996; Bukauskas et al., 2000; Anumonwo
et al., 2001; Moreno et al., 2002; Shibayama et al., 2006). A CT-
CL interaction is also important for the regulation of Cx43 HCs
by extracellular Ca2+, since a conformational change induced by
an increase of extracellular Ca2+ masks the CT from antibody
binding, which is most likely to be the result of its association
with the “receptor”-domain (Liu et al., 2006). The modulation of
HCs in response to changes in [Ca2+]i has only been outlined over
the last decade, demonstrating that HCs are differently influenced
by [Ca2+]i as compared to GJs. While GJs generally close with a
[Ca2+]i elevation, HCs display a bimodal response: a moderate
increase in [Ca2+]i up to 500 nM strongly promotes HC open-
ing while this effect disappears with [Ca2+]i > 500 nM. Further
increases in [Ca2+]i to the micromolar level tend to close the HCs
(Shintani-Ishida et al., 2007; De Vuyst et al., 2009; Wang et al.,
2012a). Mechanistically, Ca2+-activation of Cx43 HCs is medi-
ated by CaM-dependent signaling (De Vuyst et al., 2009) and
necessitates a CT-CL interaction (Ponsaerts et al., 2010). Most
notably, the necessity of CT-CL interaction to trigger opening of
Cx43 HCs stands in stark contrast to the fact that such inter-
action results in closure of GJs (reviewed in Iyyathurai et al.,
2013). Addition of a CT-mimicking peptide prevented HC clo-
sure at high [Ca2+]i and restored HC activity of CT truncated
Cx43 (Ponsaerts et al., 2010), while not affecting HC activation
by modest (< 500 nM) [Ca2+]i.
Several ODDD-associated mutations have been identified in
the CL domain, most of which are located in the L2 region.
Cx43-I130T HCs are transported to the PM and assemble into
GJ plaques. Moreover, mutant levels in the PM exceed those
of WT Cx43 which might indicate a reduced degree of protein
degradation. Despite of this, the mutant exhibits reduced dye
and electrical coupling and HC activity is disrupted (Shibayama
et al., 2005; Lai et al., 2006; Kalcheva et al., 2007). K134E/N
mutants show a reduced degree of plaque formation and electri-
cal coupling and a decrease in unitary conductance (Shibayama
et al., 2005). Both I130 and K134, forming ionic bonds with C-
terminal aspartate residues, are suggested to be involved in CT-CL
interactions (Seki et al., 2004; Hirst-Jensen et al., 2007). As dis-
cussed higher, CT-CL interactions are necessary for HC opening
while they result in closure of GJs. However, I130T and K134E
mutant channels are closed in both the GJ and HC configura-
tion, indicating that mechanisms different from altered CT-CL
interactions may contribute to the closure of GJs.
Two CL mutations located further downstream in the L2
region (G138R and G143S), result in GJ channels that fail to
sustain electrical or dye coupling and have a dominant negative
effect on WT or endogenous (NRK—normal rat kidney—cells)
Cx43. Interestingly, HC activity, measured by dye uptake and
ATP release, is increased in both mutants (Roscoe et al., 2005;
Dobrowolski et al., 2007, 2008). It is possible that the differen-
tial effects of these mutants on GJs and HCs mutants result from
reinforced CT-CL interactions, caused by stronger electrostatic
interactions between the CL equipped with an additional posi-
tively charged arginine residue (G138R), with negatively charged
residues in the CT (Gong et al., 2007). Likewise, a shift from a
non-polar glycine to a polar serine residue (G143S) may account
for a higher number of hydrogen bonds that lock the CT to the
CL. Further work is needed to substantiate these possibilities.
C-TERMINAL Cx43 MUTATIONS
As highlighted above, the CT functions as a gating particle that
alters its state in response to changes in the extra-or intracellular
environment. The CT domain is additionally the primary target
for post-translational modifications like S-nitrosylation (Retamal
et al., 2006) and phosphorylation (reviewed by Johnstone et al.,
2012). The majority of phosphorylation events occur on serine
residues although tyrosine phosphorylation is abundant as well
(Lampe and Lau, 2004; Solan and Lampe, 2007). Phosphorylation
of Cx proteins seems to be intricately involved in Cx trafficking
to the PM. Additionally, both under basal and stimulated con-
ditions, Cx channel activity appears to be regulated by ongoing
phosphorylation-dephosphorylation events. Substitution of C-
terminal serines (S325, S328, S330) by alanines has indicated that
phosphorylation of these serines is required for a fully open state
of Cx43 GJs while phosphorylation of other residues (S255, S279,
S282, S368, Y247, and Y265) favors channel closure (Ek-Vitorin
and Burt, 2013). However, much of the details on how Cx phos-
phorylation can determine trafficking, turnover and the activity
state of HCs and GJs still remains to be resolved (Johnstone
et al., 2012). One detailed example of Cx channel regulation by
phosphorylation is phosphorylation of the Cx43 CT tail by pH-
dependent kinases which might introduce negative charges at this
site, potentiating CT-CL interaction (Yahuaca et al., 2000).
Although the CT is the primary interaction domain of Cx-
associated partner proteins like zonula occludens 1, tubulin,
microtubules, and caveolins that may regulate protein traffick-
ing and function (Giepmans et al., 2001; Langlois et al., 2008;
Saidi Brikci-Nigassa et al., 2012); work with CT-truncated Cx43
mutants has repetitively shown that CT-truncated proteins are
present at the PM ofmammalian cells (Unger et al., 1999; Moreno
et al., 2002; Kang et al., 2006; Maass et al., 2007). Oppositely,
most of the ODDD-linked CT mutations are not inserted in the
PM: the frame shift mutations fs230 and fs260 result in prelim-
inary truncated Cx43 and present with reduced ability to form
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plaques while having a dominant negative effect on WT Cxs with
respect to trafficking (Lai et al., 2006; Gong et al., 2007; Churko
et al., 2011). In the atrial tissue of a patient with idiopathic atrial
fibrillation, a frame shift mutation caused by a single nucleotide
deletion (c.932delC) was identified. The mutation renders a Cx43
protein exhibiting aberrant CT amino acids starting from posi-
tion 346 followed by a premature stop codon, leading to prompt
truncation. The protein remains intracellular and exerts a dom-
inant negative effect on wild type Cx43 (as well as Cx40) in the
atrial tissue (Thibodeau et al., 2010). Importantly, all previously
reported work with CT-truncated mutants was indeed based on
exogenous expression systems and the c.932delCmutant was sim-
ilarly observed at the PM when exogenously expressed in HeLa
cells where it even sustained dye coupling, though to a smaller
extent than WT Cx43 (Hong et al., 2010). Another major differ-
ence between exogenous CT-truncated mutants and the ODDD
mutants is that in the former the CT is absent while with frame
shifts and single nucleotide deletion mutants, a CT is still (partly)
present, albeit with a wrong amino acid sequence which could
give a different outcome on trafficking.
NEUROLOGICAL PHENOTYPE IN ODDD - LINK TO ABERRANT
Cx43 CHANNELS
Apart from the physical appearances linked to ODDD, several of
the above describedmutations have been associated with seizures,
spasticity, gait difficulties, tremor and incontinence. These symp-
toms are for the bigger part clinical manifestations of underlying
neuronal damage in the central nervous system (CNS). Patients
may also suffer from hearing loss and decreased visual acuity
or blindness; however, the latter two phenotypes are infrequent
and only observed in a small fraction of the patients presenting
with neurological traits. Magnetic resonance imaging (MRI) and
computed tomography (CT) scans of patients’ brains revealed
abnormalities in both white and gray matter (Loddenkemper
et al., 2002; Amador et al., 2008; Joss et al., 2008; Paznekas
et al., 2009; Alao et al., 2010; Abrams and Scherer, 2012). One
patient was reported to exhibit central or sensorineural hear-
ing loss which is associated with damaged cranial nerve VIII
(cochlear part) that transmits signals from the cochlea to the
inner ear. Loss of visual acuity (decreased sharp vision) or blind-
ness result from atrophy of the optic nerve that relays visual
information from the retina (via the thalamus) to the visual cor-
tex. Similar loss of visual acuity follows optical nerve neuritis
observed in the demyelinating disease multiple sclerosis (Florio
and Maniscalco, 2011). Spasticity is a muscle control disorder
characterized by stiff, uncontrollable muscles with hyperreactiv-
ity toward exogenous stimulation, and is generally associated with
hyperactive, persisting reflexes (hyperreflexia). Tremor is charac-
terized by involuntary rhythmic muscle contractions. According
to the alpha/gamma-coactivation theory, muscle contraction is
controlled by both alpha and gamma motor neurons. The alpha
component delivers a feed forward command resulting in force
delivery by activating extrafusal muscle fibers. The gamma motor
component controls the length of muscle spindles (intrafusal
muscle fibers), thereby delivering input to a servo-controlled neu-
ronal circuit that receives feedback on the length status from
the sensory output of muscle spindles. Spasticity may develop
as a result of aberrantly increased gamma motor neuron activity,
resulting in increased tension in the muscle spindles that become
oversensitive to external stimulation. Increased gamma motor
drive may occur as a consequence of decreased central (cerebral
and cerebellar) inhibitory input on spinal gamma motor neurons
(reviewed in Sheean and McGuire, 2009). Ataxia is a cerebellar
phenomenon that manifests as a lack of voluntary muscle coor-
dination, typically observed as disturbances in the gait pattern.
Interestingly, one patient carrying the W25C (TM1) mutation
presented with all characteristic craniofacial features and extrem-
ity anomalies, as well as with spastic tetraparesis, hyperreflexia
and sensory disturbances (numbness in feet), indicating wide-
spread sensori-motor neurological deficits (Furuta et al., 2012).
In two siblings characterized for having an R33X mutation,
myelination deficits were described (Joss et al., 2008). The other
major neurological deficit, namely seizure activity, results from
a repetitive and synchronized, excessive neuronal activity in the
CNS. Epilepsy has long been viewed as a channelopathy and
involves epileptogenic (genesis of the disease) and ictogenic (gen-
esis of an epileptic ictus or seizure) components. Currently, our
understanding of epileptogenesis is very incomplete, at least at a
mechanistic level. Ictogenesis is related to an imbalance between
glutamatergic excitation and (mostly) GABA-ergic inhibition,
and has been associated with dysfunctional channels, mostly
voltage-gated Na+, K+, Cl−, and Ca2+ channels that determine
neuronal action potential firing. Moreover, the extracellular con-
centration of Na+, K+, Cl−, and Ca2+ may influence the glial cells
and thereby exert control over neuronal activity. It is hypothe-
sized that dysfunctional Na+, K+, Cl−, or Ca2+ channels alter the
threshold for neuronal depolarization and action potential firing,
thereby shifting the balance between excitation and inhibition.
At the microscopic level, epileptic brain regions are characterized
by injured neurons, gliosis, axonal sprouting, and the formation
of new, aberrant, synaptic connections (reviewed in D’Ambrosio,
2004; Dichter, 2009; Reid et al., 2009).
Cx43 is abundant in astrocytes and can additionally be found
in activated microglia, developing neurons, and endothelial cells
(Orellana et al., 2009, 2011; Avila et al., 2011; Wang et al., 2012b)
(Figure 1). Given its ubiquitous presence, it is not surprising that
around 30% of the ODDD patients exhibit neurological symp-
toms. This number may further increase as neurological inves-
tigations of ODDD patients are becoming progressively more
detailed.
ODDD-ASSOCIATED MUTATIONS AND THEIR IMPLICATIONS FOR
ASTROCYTE FUNCTIONING IN THE NEUROGLIOVASCULAR UNIT
Despite being originally described as “brain glue,” established
functions of glia nowadays suggest an active role in brain func-
tion and information processing (reviewed in Allen and Barres,
2009). Together with neurons, glial cells work in concert with vas-
cular and blood cells to establish the neurovascular unit, which
should better be called the neurogliovascular unit (Figure 1). The
concept of a neurogliovascular unit has been central in explor-
ing improved strategies and approaches to treat stroke patients
(reviewed in Berezowski et al., 2012; Kur et al., 2012).
Astrocytes are involved in key aspects of the nervous tissue
including preservation of blood-brain barrier (BBB) integrity,
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FIGURE 1 | Connexins in the neurogliovascular unit. The
neurogliovascular unit is a functional unit in which astrocytes are centrally
involved. Astrocytic endfeet are tightly associated with endothelial cells that
form the BBB while at their other site, astrocytes contact pre- and
postsynaptic neuronal membranes. Additionally, astrocytes may contact
other glial cells like microglia and oligodendrocytes. Each of the cell types in
the neurogliovascular unit is endowed with a set of connexins proteins.
Importantly, Cx43 is present in astrocytes as well as in BBB endothelial
cells and microglial cells.
modulation of blood supply, maintenance of brain homeostasis,
myelination, and neurotransmission. The combined ablation
of Cx30 and Cx43, which results in coupling-deficient astro-
cytes, lowers the threshold for epileptiform events (Theis et al.,
2003; Wallraff et al., 2006), alters astrocyte energy metabolism
(Rouach et al., 2008), gives rise to swollen astrocytic end-
feet (Ezan et al., 2012) and leads to parenchymal vacuolation
(Lutz et al., 2012). Astrocyte-targeted deletion of Cx43 severely
reduces cell–cell coupling although it is not completely abol-
ished, likely due to compensatory actions of Cx30 (Theis et al.,
2003; Wallraff et al., 2006; Unger et al., 2012). Astrocyte-specific
Cx43-ablated mice have been shown to exhibit reduced motor
performance (Frisch et al., 2003), similar to ODDD patients suf-
fering from cerebellar ataxia; yet, astrocyte-targeted deletion of
Cx43 does not affect viability or astrocyte morphology nor does
it cause neurodegeneration or astrogliosis (Theis et al., 2003).
Conclusions from knock-out studies should be drawn with cau-
tion, as recent work in the heart has indicated that transgenic
animals with a 5 amino acid deletion of the Cx43 CT have
a much stronger cardiac phenotype than those with a com-
plete deletion of the CT (Lubkemeier et al., 2013). In addition,
mice missing one copy of the Cx43 allele do not mimic ODDD
(Paznekas et al., 2009).
Below we describe how aberrant astrocytic signaling, due to
defective Cx43, may contribute to ODDD-linked neurological
symptoms.
Connexins and astrocytes contribute to blood-brain barrier function
Proper electrical signaling in the CNS requires a strict composi-
tion of the microenvironment around synapses and axons. The
composition of the brain interstitial fluid is largely maintained
by capillary endothelial cells that constitute the blood-brain bar-
rier (BBB) and that survey solute diffusion in and out the brain
(a highly comparable barrier is present between the capillaries
and nervous tissue in the spinal cord). Astrocytic endfeet nearly
completely enwrap these capillary endothelial cells, inducing and
maintaining barrier properties. Cx43 may contribute to astrocyte
maintenance of the endothelial barrier, as mice lacking Cx30 and
astroglial Cx43 have a weakened BBB that is more vulnerable to
hydrostatic vascular pressure and shear stress but that is other-
wise intact in the absence of a pathological insult (Ezan et al.,
2012; Lutz et al., 2012). It is not known whether this is medi-
ated by the Cx protein itself or by an effect related to GJs or HCs.
It is equally unknown whether a putative GJ involvement would
be limited to GJs between astrocytic endfeet or between endfeet
and endothelial cells. In vitro evidence has suggested astrocyte-
endothelial communication via GJs (as well as HCs) (reviewed
in Braet et al., 2001), but in vivo evidence argues against this
possibility (Simard et al., 2003).
In a first approximation, it is conceivable that Cx43 muta-
tions that result in a trafficking defect or loss of channel function
may give similar manifestations as Cx43 silencing. BBB leakage
enables the entry of potentially neurotoxic, circulating com-
pounds that directly affect neuronal survival, but also gives rise
to inflammation, edema and hypoxia, which will ultimately result
in additional injury to the neural tissue. At the same time, the
ionic homeostasis of the brain’s interstitial compartment becomes
disturbed, particularly the increased K+ concentration will inter-
fere with action potential propagation and synaptic transmission.
Additionally, influx of albumin and other circulating compounds
can cause astrogliosis, characterized by the upregulation of GFAP
(glial fibrillary acidic protein), astrocyte swelling and prolifera-
tion (David et al., 2009; Das et al., 2012), and promote extra-
cellular K+ accumulation by indirect effects (Ivens et al., 2007;
Janigro, 2012), favoring seizural activity bymechanisms described
below.
Connexins and astrocytes control nutrient supply to the nervous
tissue
While astrocytic endfeet contact the BBB endothelium and its
associated basement membrane at one side, at the other end,
astrocytic processes project toward pre- and postsynaptic neu-
ronal membranes forming the “tripartite synapse” (Allen and
Barres, 2009). Here, astrocytes exert homeostatic control over
neural network excitability: they provide neurons with energy
and substrates for neurotransmission while removing excessive
neurotransmitters and K+ from the extracellular space by spa-
tial buffering and siphoning. As such, neurons are protected from
energy deprivation, large depolarisations and hyperexcitation that
would eventually lead to neuronal death.
Astrocytes control blood flow and nutrient (oxygen and glu-
cose) supply to those regions where neuronal activity is high by a
process termed functional hyperemia or neurovascular coupling
that acts at the level of cerebral arterioles and possibly also peri-
cytes (Zonta et al., 2003 and reviewed in Iadecola andNedergaard,
2007; Attwell et al., 2010; Petzold and Murthy, 2011). Unlike
peripheral arterioles where the vasomotor response is propa-
gated along smooth muscle cells, these do not seem to play a
role in the regulation of blood flow in the CNS. Indeed, Xu
et al. (2008) have shown that selective astrocyte death abolishes
vasodilation despite the continued presence of viable smooth
muscle cells (Xu et al., 2008). Although less documented, the
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vasomodulatory action of astrocytes can also imply a vasocon-
striction (Mulligan and MacVicar, 2004; Metea and Newman,
2006; Filosa and Blanco, 2007; Gordon et al., 2008). Candidate
astrocyte messengers mediating the vasomotor response include
K+ as well as gliotransmitters (glutamate, ATP, adenosine, and
NO) and arachidonic acid metabolites (reviewed in Mulligan and
MacVicar, 2004; Koehler et al., 2006; Iadecola and Nedergaard,
2007; Attwell et al., 2010). A Cx43 mimetic peptide that prevents
both HC opening and GJIC, has been shown to prevent neu-
rovascular coupling (Xu et al., 2008); however, it remains to be
established exactly how Cx channels contribute to neurovascular
coupling. Likely, Cx channels mediate the propagation of ICWs
between astrocytes, possibly spreading the vasomotor response.
Increased blood flow in local parenchymal capillaries requires
for example an upstream vasodilation in arterioles and pial ves-
sels, whichmight be communicated by Cx-based astrocytic ICWs.
ICWs rely on both a direct communication of Ca2+ mobilizing
messengers mediated by GJs and an paracrine route involving
the release of a Ca2+ mobilizing messenger in the extracellular
space (Leybaert and Sanderson, 2012). Astrocytic Ca2+ changes
play a key role in neurovascular coupling (Takano et al., 2006),
with rises in [Ca2+]i along the path of the Ca2+ wave enabling the
release of vasoactive messengers (Zonta et al., 2003; Mulligan and
MacVicar, 2004). Additionally, HCs may provide a release path-
way for vasoactive substances, yet this remains to be determined.
Defective GJIC or HC responses are expected to disable ICWs and
neurovascular coupling, resulting in a relative oxygen and glucose
shortage during neuronal activity that may lead to convulsions
and, on a longer term, to neuronal cell death. Chronically dis-
turbed neurovascular coupling may lead to neurodegeneration
(Zlokovic, 2011; Lasta et al., 2013) and this may be a possible
mechanism at the basis of the motor deficiencies observed in
ODDD patients.
Connexins and astrocyte modulation of synaptic transmission
Neuronal action potential firing is always accompanied by an
increase of K+ levels in the extracellular space. Astrocytes buffer
these excessive K+ ions through inward rectifier K+ channels
(Kir4.1) aided by Na+/K+ pump activity and passive uptake with
water through aquaporin 4 channels. Altered activity of both
K+ channels and Na+ channels in the astrocyte PM are con-
sidered pro-epileptic (D’Ambrosio, 2004). Subsequently, K+ is
redistributed over networks of GJ-connected astrocytes (reviewed
in Carlen, 2012; Steinhauser and Seifert, 2012). Like K+, gluta-
mate, the brain’s major excitatory neurotransmitter, is taken up
and diluted in those astrocytic networks during synaptic activity,
keeping its levels in the synaptic cleft low and sheltering neu-
rons from excitotoxic injury. Inside the astrocytes, glutamate is
converted to glutamine that is shuttled back to presynaptic nerve
terminals where it is reconverted to glutamate. Disturbed redis-
tribution of glutamate and K+ in the astrocytic networks, via GJ
loss or abnormal GJ channel gating and permselectivity, may lead
to a local accumulation of both substances, paving the way for
epileptic seizure activity (reviewed in Pannasch et al., 2011). The
swelling of astrocytes may additionally result in a decreased extra-
cellular space volume further increasing ambient concentrations
of K+ and glutamate sensed by neurons. Reduced expression of
Cx43 has been shown to increase expression of glutamate trans-
porters (Unger et al., 2012), likely as a means to compensate the
inadequate uptake of glutamate form the extracellular environ-
ment; its functional implications are, however, unknown. Also
note that the clearance and redistribution of K+ is partially main-
tained in the hippocampus when Cx43 and Cx30 expression is
silenced in astrocytes (Wallraff et al., 2006), indicating that mech-
anisms other than those related to astrocytic Cxs contribute to
spatial buffering.
More than just exerting homeostatic control over the extracel-
lular compartment, astrocytes are now considered to also more
actively contribute to synaptic transmission, by responding to
neuronal activity and releasing gliotransmitters. Individual astro-
cytes can contact up to 140,000 synapses (Bushong et al., 2002)
and express a plethora of neurotransmitter receptors that in most
cases trigger an increase in [Ca2+]i. In response to this, they
release gliotransmitters that include glutamate, D-serine, ATP,
adenosine, and GABA of which neurones on their turn express
receptors (Perea and Araque, 2010; Orellana et al., 2011; Pannasch
et al., 2012). HCs composed of Cx43 may well-contribute to
gliotransmitter release as a [Ca2+]i-controlled diffusive path-
way: HCs open with a [Ca2+]i increase up to 500 nM and close
again at higher concentrations (see Cx43 Mutations Located in
the Cytoplasmic Loop). Stehberg and co-workers have tested the
hypothesis of gliotransmitter release via HC opening by making
use of an inhibitory peptide (L2 peptide) that specifically tar-
gets Cx43 HCs without inhibiting Cx43 GJs (Ponsaerts et al.,
2010). This work, performed in vivo, demonstrated that stereo-
tactic injection of this peptide (coupled to a TAT-translocation
motif) in the basolateral amygdala, blocked the consolidation
of fear memory while addition of a cocktail of putative glio-
transmitters rescued the L2-mediated inhibition of fear memory
consolidation (Stehberg et al., 2012). Besides being activated by
a moderate [Ca2+]i increase, HCs are also activated by a lower-
ing of extracellular Ca2+. Extracellular Ca2+ can decrease as a
result of neuronal activity and Nedergaard and co-workers have
recently demonstrated that this may trigger astrocytic HC open-
ing with consequent ATP release (Torres et al., 2012). The latter
was demonstrated to activate inhibitory interneurons that put
a brake on excitatory firing (Torres et al., 2012). Additionally,
adenosine, derived from ATP degradation, has anticonvulsant
effects as it inhibits presynaptic neurotransmitter release (Pascual
et al., 2005). Overall, HC activation in astrocytes may thus
contribute to gliotransmitter release, but with the evidence
presently available, this may lead to excitatory as well as inhibitory
signaling.
The contribution of Cx channels to ictogenesis has an ambigu-
ous, two-faced aspect: on the one hand GJs have an anti-
convulsive effect with respect to their K+ and glutamate buffering
capacity, but on the other hand, GJs may act in a pro-convulsive
way as well. In this respect, Cx43 gene ablation or pharma-
cological block of GJs reduced seizure activity while agents
that potentiate cell–cell coupling enhanced neuronal bursting
(Kohling et al., 2001; Wallraff et al., 2006; Yoon et al., 2010).
Mechanistically, neuron-derived glutamate may trigger a [Ca2+]i
increase in astrocytes that further stimulates glutamate release
from these cells. The Ca2+ signal can propagate to neighboring
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astrocytes in the form of an intercellular Ca2+ wave, modulating
groups of remotely located synapses and inducing a hyperex-
cited [Ca2+]i state over the entire astrocyte network (Giaume,
2010). Additionally, astrocyte GJs provide an intercellular route
for the supply of energy substrates like glucose and lactate that
are required for neuronal activity (Rouach et al., 2008). Once
the astrocytic distribution of these substrates is compromised,
energy delivery may become below demand, causing the accu-
mulation of glutamate and K+ that may act in a pro-convulsive
manner. Finally, both GJs and HCs have been implicated in
the spread of apoptosis between astrocytes (Nodin et al., 2005;
Eugenin and Berman, 2007; Decrock et al., 2009) which may
well-break ground for epileptic seizures (Briellmann et al., 2002;
Willoughby et al., 2003; Kang et al., 2006). With respect to HCs,
Cx43 mutations giving a gain of HC function (I31M, G143S, and
G138R) are, theoretically, expected to result in increased neu-
ronal cell death, caused by excessively elevated neuronal [Ca2+]i
(reviewed in Bennett et al., 2012). However, up to date, none of
these gain-of-function mutants has been associated with epilep-
tic seizures in ODDD patients (Abrams and Scherer, 2012). On
the other hand, some mutants that result in a loss of HC func-
tion (L90V and I130T) are also associated with epileptic seizure
activity which may result from a decrease in ATP release and con-
sequent inhibitory signaling. At this stage, it is not clear what the
net effect of an astrocytic HC contribution would be on excitabil-
ity and ictogenesis but it emerges that the involvement of HCs
in ictogenesis is, like for GJs, a double-edged sword. The use of
novel tools such as the Gap19 peptide (Wang et al., 2013a) and
the L2 peptide (Ponsaerts et al., 2010; Stehberg et al., 2012) may
shed more light on the role of HCs in the healthy or pathologi-
cal brain. In comparison to non-specific Cx channel blockers and
peptides like Gap26/Gap27, L2/Gap19 peptides specifically block
HCs composed of Cx43 (but not those composed of Cx40 and
Panx1) while not blocking GJs.
When looking over the currently available evidence for
ODDD-associated epilepsy, seizures have been reported in
patients exhibiting mutants that give both dysfunctional HCs and
GJs (Table 2); the loss of efficient K+ and glutamate buffering and
inadequate nutrient supply may thus play a primary role in the
appearance of an epileptic phenotype in ODDD, although this
requires further research. Epilepsy has thus far not been reported
for mutants with a gain of HC function.
Table 2 | List of ODDD-linked mutations associated with epileptic
seizures and their effect on Cx43 HCs and GJs.
Mutant PM presence and plaque
formation
GJIC HC function
G2fs n.a. n.a. n.a.
R76S Normal presence in PM X n.a.
L90V Normal GJ plaques ↓ X
I130T Increased presence in PM but
reduced number of GJ plaques
↓ X
n.a., no data available.
X, absence of detectable GJIC or HC activity.
Connexins and astrocyte-oligodendrocyte interactions involved in
axonal myelination
As a last example of the astrocytic contribution to normal CNS
function we highlight the role of astrocytes in axonal myeli-
nation. Astrocytes themselves do not produce myelin, but they
are connected to oligodendrocytes, the brain’s myelinating cells,
via Cx43/Cx47 GJs (Orthmann-Murphy et al., 2007). Loss-of-
function mutations in the Cx47 gene (GJA12/GJC2) lie at the
basis of Pelizaeus-Merzbacher-like disease (PMLD1), an early
onset, progressive dysmyelinating disorder affecting the CNS, and
are also known to cause a distinct form of late onset heredi-
tary spastic paraplegia (SPG44). In both cases, Cx47 mutations
prevent the formation of functional Cx47/Cx47 and Cx43/Cx47
GJs causing hypomyelinating leukoencephalopathy (Orthmann-
Murphy et al., 2007, 2009). The role of astrocyte-oligodendrocyte
GJs is unclear but possibly relates to K+ shunting between
both cell types. Although astrocytes and oligodendrocytes are
also connected through Cx30/Cx32 GJs, these do not seem to
compensate for the loss of Cx43/Cx47 coupling, probably as a
consequence of differences in conductance, gating, and perme-
ability (Orthmann-Murphy et al., 2007). We expect that spastic-
ity observed with ODDD is similarly related to non-functional
Cx43/Cx47 GJs caused by mutations in the GJA1 gene; however,
there are, to our knowledge, no records that address astrocyte-
oligodendrocyte coupling with ODDD-linked Cx43mutants. The
observation of a severe downregulation of astrocytic Cx43 in
demyelinating lesions of patients suffering from Baló’s disease,
a disorder characterized by astrocytopathy and demyelination
(Masaki et al., 2012), may give credit to the hypothesis that aber-
rant Cx43 function in astrocytes results in anomalous axonal
myelination.
Finally, the retention of processed or unprocessed Cx43 pro-
tein can cause glial cell death through a process known as the
“unfolded protein response” or through ER stress (reviewed
by Roussel et al., 2013). The unfolded protein response and
ER stress have been implicated in different neurodegenerative
diseases, including those with progressive motor dysfunction
(Huntington’s disease, amyotrophic lateral sclerosis) as observed
in ODDD as well.
IMPLICATIONS OF ODDD-LINKED MUTATIONS IN CNS CELLS OTHER
THAN ASTROCYTES
BBB-ECs
The role of Cxs, including Cx43, in BBB endothelial cells is only
starting to emerge. Endothelial GJs have been implicated in main-
tenance of the interendothelial junctional complex (Nagasawa
et al., 2006) and more recently, we have shown that Ca2+
dynamics triggered by low extracellular Ca2+ or inflammatory
substances were sustained by GJs and HCs and contributed to dis-
turbed BBB function and increased permeability (De Bock et al.,
2011, 2012, 2013). Additionally, work from others has indicated
that Cx43 HCs contribute to endothelial cell loss during patho-
logic insults (Danesh-Meyer et al., 2012). The effect of a Cx43
loss-of-function has not been studied at the level of the BBB,
although one might expect a dysfunctional barrier due to a dis-
organisation of the junctions. On the other hand, following the
observation that HCs contribute to increasing permeability, those
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mutants exhibiting increased HC activity are expected to render
the BBB leaky to circulating compounds. The implications of such
a leaky BBB have been outlined above.
Neurons
Cx43 is not expressed in adult neurons but it is prominently
present in neuroblast cells where its role in embryonic devel-
opment of the cortex becomes more and more acknowledged.
Radial glial cells, the neuronal stem cells of the embryonic cere-
bral cortex, originate in the ventricular zone and differentiate into
neuronal cells as the neocortex forms. These neuronal cells sub-
sequently migrate to their final destination in the cortical plate.
Additionally, radial glia give rise to radial fibers that form a guid-
ance scaffold for neuronal migration. Cx43 can be found in the
neuronal progenitors (or neuroblasts) as well as in the glial scaf-
fold. Expression of the Cx43-T154A mutant that is able to make
adhesions but is unable to form functional GJ channels in the
developing cortex did not abolish the migration of new born neu-
rons, but expression of the Cx43-C61S mutant that lacks docking
ability (with maintained HC function) did prevent migration of
new neurons. These observations suggested that channel activ-
ity does not play a role but Cxs are involved as adhesive contact
points between the scaffold and the migrating neurones (Elias
et al., 2007). More recently, it was shown that conditional Cx43
knock-out in radial glia disrupts neuronal migration, and this
could be rescued by expression of full-length Cx43 but not
by expression of CT-truncated Cx43 (removal of the last 125
residues) (Cina et al., 2009). These findings indicate that the C-
terminal tail, which is known to interact with scaffolding proteins
like ZO-1 and cytoskeletal tubulin (Giepmans et al., 2001), cru-
cially links adhesive Cx43 properties to the cytoskeleton. Cx43
additionally co-localizes with proteins specialized in cell adhe-
sion to neighboring cells or to the extracellular matrix (Nagasawa
et al., 2006; Li et al., 2010; Sato et al., 2011). Although both
studies suggest that the Cx43 channel pore has no function in
neuronal migration, other studies have indicated that Cx43 HCs
and GJs play a role in the initiation and propagation of Ca2+ sig-
nals in and between neuronal precursor cells respectively. These
Ca2+ signals are likely to play a role in neuronal proliferation.
Blocking HCs/GJs reduced neuronal motility, likely by interfering
with Rho-GTPase activity, and gave rise to defective neurogenesis
(Weissman et al., 2004; Liu et al., 2008, 2010). Cx43 knock-out
mice generally do not present with a severely distorted cortex
which might be explained by the fact that other Cxs like Cx30
or Cx26 contribute to neuronal migration (Elias et al., 2007),
compensating for the loss of Cx43. One mouse strain that lacks
Cx43 in embryonic radial glia, termed Shuffler, mimics part of
the neuronal phenotype observed inODDD (gait disturbance and
ataxia). The mice exhibit structural abnormalities in the cerebel-
lum, hippocampus and cortex which can explain the neuronal
deficits. Importantly, the phenotype of these mice differs from
other Cx43 knock-out mice strains in which no neurological phe-
notype was observed, suggesting that the genetic background is an
important determinant of the occurrence of neurological symp-
toms (Wiencken-Barger et al., 2007). Such effect may apply for
humans as well and might account for the rather low prevalence
of neurological manifestations in ODDD patients.
Microglia
Microglial cells are the resident innate immune effector cells
of the CNS and are essential in the primary defense against
pathologic insults. Resting amoeboid microglia continuously
scan the nervous tissue and rapidly respond to inflammatory
molecules, pathogens or tissue injury by transforming into ram-
ified cells that exhibit a high rate of proliferation and migration
(reviewed in Kettenmann et al., 2011). Their activation involves
the release of pro-inflammatory cytokines, free radicals and glu-
tamate (Candelario-Jalil et al., 2007; Sumi et al., 2010; Takeuchi
et al., 2011) which are all generally believed to be neurotoxic.
Indeed, microglial activation is observed in many neurodegener-
ative diseases including Alzheimer’s disease, Parkinson’s disease,
Huntington’s disease, and amyotrophic lateral sclerosis (Orellana
et al., 2009) as well as in epilepsy (reviewed in Mirrione and
Tsirka, 2011; Vezzani et al., 2012). In addition to direct neurotoxic
effects, cytokines and other molecules released by microglia may
inhibit GJIC between astrocytes (Meme et al., 2006) while stim-
ulating HCs (Retamal et al., 2007), or activate BBB endothelial
cells (Orellana et al., 2009), further contributing to neurodegen-
eration and epilepsy via mechanisms described above. However,
in certain scenarios, microglia may also contribute to CNS repair
through scavenging of reactive oxygen species, the release of
neurotrophic factors and the removal of neurotoxic substances
(Rouach et al., 2004, reviewed in Mika and Prochnow, 2012;
Aguzzi et al., 2013). The role of Cx43 in the CNS’ immune
cells is uncertain. Whereas some groups find no indication for
the presence of microglial Cx43 in the resting or ramified state
Table 3 | List of ODDD mutations linked to upper motor neuron
dysfunction, tremor, gait disturbances, and spasticity, indicating
neurodegeneration.
Mutant PM presence and plaque
formation
GJIC HC function
D3N Normal number of plaques ↓ n.a.
Y17S Reduced presence in PM with
reduced number of GJ plaques
X X
G21R Reduced number of GJ plaques X X
K23T Normal GJ plaques n.a. n.a.
R33X Not present in PM X X
A40V Reduced number of GJ plaques X X
L90V Normal GJ plaques ↓ X
H95R n.a. n.a. n.a.
L106P n.a. n.a. n.a.
L113P n.a. n.a. n.a.
I130T Increased presence in PM but
reduced number of GJ plaques
↓ X
K134E/N Reduced number of GJ plaques ↓ X
G138R Increased presence in PM with
normal number of GJ plaques
X ↑
T154A/N Normal number of GJ plaques ↓ n.a.
V216L Reduced number of GJ plaques ↓ n.a.
n.a., no data available.
X, absence of detectable GJIC or HC activity.
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(Dobrenis et al., 2005; Theodoric et al., 2012), others do report
an increase in microglial Cx43 in inflammatory conditions
(Eugenin et al., 2001; Garg et al., 2005; Shaikh et al., 2012).
HCs have been implicated in glutamate release which could con-
tribute to neuronal/astrocyte cell death and epilepsy (Ye et al.,
2003; Takeuchi et al., 2008). In addition, dye coupling between
microglial cells has been observed upon exposure to inflamma-
tory conditions (Eugenin et al., 2001; Martinez et al., 2002). The
functional implications of this activation-dependent microglial
coupling remain unclear. Similar as in peripheral immune cells
where Cx43 levels increase during inflammation, GJs could be
involved in the cell–cell transfer of immunogens, rendering anti-
gen cross-presentation more efficient (Neijssen et al., 2005).
Altogether, altered Cx43 expression/channel function could dis-
turb the proper microglial response to inflammation, failing in
the defense against neurodegenerative mediators but contributing
to neuronal bursting activity.
CONCLUSIONS
ODDD manifests as a pleiotropic disease with patients exhibit-
ing both morphological and functional deficiencies caused by
mutations in the widespread GJA1 gene. The GJA1 gene product
Cx43 plays a leading role in CNS physiology and it thus comes
with no surprise that neurological symptoms are included in the
still expanding list of ODDD features. Analysis of the different
mutants demonstrates that they can either alter insertion of Cx43
in the PM, GJ channel formation or HC/GJ channel gating. All
CNS cells expressing aberrant Cx43 are potential contributors to
nervous tissue dysfunction or damage, with a major involvement
of astrocytes as the prime cell type expressing Cx43. In this paper
we gave an overview of those mutants associated with nervous
tissue dysfunctioning along with their outcome on Cx43 func-
tion. The information currently available on the possible effects
of ODDD-linked mutations on Cx43 expression/channel func-
tion is impressive, as can be appreciated from Table 1. However,
there is still a paucity of reports that document and analyze the
mechanism by which the mutants give the neurological pheno-
type in a detailed manner. Thus, it remains difficult to present a
clear genotype/phenotype correlation. None of the mutants iden-
tified thus far have been characterized for their specific effect on
the function of astrocytes or other cells of the neurogliovascular
unit, and therefore, genotype/phenotype linkage still remains in
the realm of speculation. ODDD is, with a few exceptions, subject
to an autosomal dominant inheritance pattern but unfortunately,
thus far, there is no clear hypothesis that explains this pattern.
Having one dysfunctional allele may cause a CNS phenotype in
ODDD while in homozygous astrocyte-specific Cx43 knock-out
animals no severe alterations are observed (Theis et al., 2003).
This observation may plead in favor for a dominant negative
effect of mutant Cx43 on co-expressed WT Cx43 protein. Most
of the Cx43 mutants exhibit dominant negative effects, but a
comparison of dominant negative mutants and neurological phe-
notypes is unfortunately inconclusive. The dominant negative
effect of Cx43 mutants does not guarantee neurological find-
ings (see for instance L11P and S18P) while mutants that do not
exert a dominant effect may give a severe neurological phenotype
(I130T). Trans-dominant negative effects of the mutants on other
co-expressed Cxs are another likely explanation. Such effects have
for instance been used to explain the dominant expression pat-
tern of syndromic deafness caused by GJB2 (Cx26) mutations
(reviewed in Laird, 2008). On the other hand, loss-of-function
mutations of Cx26 and Cx30 have thus far not been associated
with neuropathology (Abrams and Scherer, 2012). In the heart,
Cx43-R33X mutants exert trans-dominant effects on Cx37 and
Cx40 (Huang et al., 2013), whereas G138R does not (Dobrowolski
et al., 2008). Unfortunately, we are not aware of any studies tack-
ling this question with regards to the CNS. The (trans-)dominant
effect of Cx43 mutants may additionally be cell type specific
as the mouse G60S mutant has dominant negative effects on
WT Cx43 in ovarian granulosa cells (Flenniken et al., 2005) but
not in astrocytes (Wasseff et al., 2010). Finally, as illustrated in
Table 2, epilepsy seems to be associated with loss of function
ODDD mutants. We carefully checked this for motor deficiencies
(Table 3) and found that a motor phenotype is always associ-
ated with mutants that give a loss or reduction of GJs, while
the mutant’s effects on HC function are variable. This gener-
ates a number of interesting working hypotheses that are open
to be tested, hopefully strengthening our understanding of how
ODDDmutants lead to channelopathy, CNS cell dysfunction and
neurodegeneration.
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